Continuing Education Courses
Continuing Education for MLS & MLT
Continuing Education for Phlebotomists
Continuing Education for Histologists
HR Courses
Intro to the Medical Lab
Video Continuing Education Courses
All Available Courses
Exam Simulators
Exam Simulator for MLS & MLT
NSH + LabCE Histology Exam Simulator
Phlebotomy Exam Simulator
Molecular Exam Simulator
Case Simulators
RBC Morphology Simulator
White Blood Cell Differential Case Simulator
Advanced WBC Differential Case Simulator
Urinalysis Case Simulator
Body Fluid Case Simulator
Bacteriology Case Simulator
Blood Culture Gram Stain Case Simulator
LabCE Quiz Game
Contact & Support
Log In
Log In
Warfarin
This version of the course is no longer available.
Need multiple seats for your university or lab?
Get a quote
The page below is a sample from the LabCE course
. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.
Learn more about (online CE course)
Warfarin
Warfarin
is a small molecule that is able to be absorbed by the gastrointestinal system. It is available in a pill form.
Mechanism of action:
Warfarin
prevents vitamin K from modifying factors II, VII, IX, and X in the liver. Without this modification from the liver, those factors cannot function in the coagulation cascade appropriately. This action by
warfarin
results in anticoagulation.
Warfarin
cannot change factors that have already been made by the liver, so its impact is not as immediate as
heparin
.
Use:
Warfarin
is used in the chronic management of excessive coagulation (hypercoagulable state). It is common to see a "heparin bridge," during which time heparin or LMW heparin is used for a short period while the patient also begins their
warfarin
. This allows the
warfarin
to obtain a therapeutic blood level. The goal is to achieve an
INR of 2-3
in hypercoagulable states or
2.5-3.5
in patients with mechanical heart valves. As soon as the target INR is obtained,
heparin
is stopped.
Laboratory measurement:
The PT/INR assay monitors
warfarin
. As with the aPTT, the PT assay is measured in seconds. Clinicians use the calculated International Normalized Ration (INR) value to determine the effectiveness of a patient's
warfarin
, however. The INR result accounts for differences in reagents from laboratory to laboratory, allowing a physician to understand the result no matter where a patient's PT is tested.
Toxicity:
Anticoagulants can cause excessive bleeding and
warfarin
is no different. If a patient has a supratherapeutic (above goal) INR, vitamin K is given by either orally or via injection. The vitamin K injection can overwhelm the vitamin K inhibiting properties of
warfarin
, but this is a slow process. If rapid measures are needed, fresh frozen plasma (FFP) is used as a supply of coagulation factors. In 2016, a new treatment for rapid
warfarin
reversal became available-
prothrombin complex concentrate (PCC)
. Note that
warfarin
cannot be used in pregnancy due to teratogenic effects.
X
×